When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Coccidioidomycosis

Last reviewed: 6 Apr 2025
Last updated: 27 Feb 2024

Summary

Definition

History and exam

Key diagnostic factors

  • asymptomatic
  • fever
  • cough
  • rash
Full details

Other diagnostic factors

  • headache
  • fatigue
  • pleuritic chest pain
  • dyspnea
  • myalgia or arthralgia
  • weight loss
  • night sweats
  • chills
  • rales, rhonchi, wheeze, or rub
  • bronchial breathing
  • hemoptysis
  • pyopneumothorax
  • lymphadenopathy
  • abnormal mental status or neurologic exam
Full details

Risk factors

  • immunosuppression, especially suppression of cell-mediated immunity
  • occupation involving digging or construction
  • recreational activities that increase likelihood of dust inhalation
  • extremes of age
  • male sex
  • residing in or visiting endemic areas
  • African-American or Filipino ancestry
  • blood group B
  • pregnancy
  • HLA groups
  • diabetes mellitus
Full details

Diagnostic tests

1st tests to order

  • sputum culture
  • enzyme immunoassay serology for coccidioidomycosis
  • immunodiffusion serology for coccidioidomycosis
  • complement fixation serology for coccidioidomycosis
  • CBC
  • chest x-ray
Full details

Tests to consider

  • antigen testing
  • polymerase chain reaction (PCR)
  • lung biopsy
  • lumbar puncture
  • erythrocyte sedimentation rate
  • CT chest
  • bone scan
  • MRI
Full details

Emerging tests

  • lateral flow assay (LFA)

Treatment algorithm

ACUTE

mild coccidioidal pneumonia (nonpregnant)

severe or diffuse coccidioidal pneumonia (nonpregnant)

pulmonary nodule (nonpregnant)

asymptomatic pulmonary cavity (nonpregnant)

symptomatic pulmonary cavity (nonpregnant)

chronic progressive fibrocavitary coccidioidomycosis (nonpregnant)

skin and soft tissue coccidioidomycosis (nonpregnant)

skeletal coccidioidomycosis (nonpregnant)

coccidioidal meningitis (nonpregnant)

pregnant

Contributors

Authors

Janis E. Blair, MD

Professor of Medicine

Mayo Clinic College of Medicine and Sciences

Rochester

MN

Division of Infectious Diseases

Mayo Clinic

Phoenix

AZ

Disclosures

JEB declares that she has no competing interests.

Peer reviewers

Susan Hoover, MD

Infectious Diseases Clinic

Sanford Health Sioux Falls

SD

Disclosures

SH declares that she has no competing interests.

Astrid Mayr, MD

Professor of Medicine

Department of Hygiene and Medical Microbiology

Medical University Innsbruck

Innsbruck

Austria

Disclosures

AM declares that she has no competing interests.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Thompson GR 3rd, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021 Dec;21(12):e364-74. Abstract

Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016 Sep 15;63(6):e112-46.Full text  Abstract

Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections and diseases - coccidioidomycosis/valley fever. May 2023 [internet publication].Full text

National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Coccidioidomycosis. 2021 [internet publication].Full text

Hage CA, Carmona EM, Epelbaum O, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019 Sep 1;200(5):535-50.Full text  Abstract

Limper AH, Knox KS, Sarosi GA, et al; American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011 Jan 1;183(1):96-128.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Differentials

    • Tuberculosis
    • Nontuberculous pulmonary mycobacterial infections
    • Community-acquired pneumonia
    More Differentials
  • Guidelines

    • CDC Yellow Book: health information for international travel - coccidioidomycosis/valley fever
    • Clinical testing guidance for coccidioidomycosis, histoplasmosis, and blastomycosis in patients with community-acquired pneumonia
    More Guidelines
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer